ClinicalTrials.Veeva

Menu

Clinical, Molecular and Electrophysiological Profiling of Parkinson's Disease: the Role of Non-pharmacological Therapies

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Parkinson Disease

Treatments

Other: iTBS
Other: physical activity

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

In Parkinson's disease (PD), direct evidence linking inflammation to the harmful activities of alpha-synuclein (a-syn) aggregates, the disease onset, and its progression is still lacking. This translational project aims to reveal the causal relationship between a-syn and inflammation. The investigators will also investigate the mechanisms underlying the beneficial effects of two non-pharmacological approaches, motor exercise and neuromodulation, with particular focus on neuroinflammation and brain-derived neurotrophic factor (BDNF) production. the investigators will investigate the molecular pathways and synaptic alterations underlying disease progression. This will be paralleled by a clinical study, in which clinical assessment will be associated with cerebrospinal fluid (CSF) and blood neurodegeneration and inflammatory biomarkers measures. Then, the investigators will test the hypothesis that intensive exercise and neuromodulation may reduce neuroinflammation and a-syn spreading via the activation of BDNF-related pathways.

Enrollment

400 estimated patients

Sex

All

Ages

30 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinically established diagnosis of PD according to the Movement Disorders Society (MDS) diagnostic criteria
  • Hoehn & Yahr (H&Y) stage between 1 and 3

Exclusion criteria

  • Pregnancy
  • Oncological or autoimmune comorbidities

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

400 participants in 5 patient groups

Biomarkers
No Intervention group
physical activity
Active Comparator group
Treatment:
Other: physical activity
sedentary
No Intervention group
iTBS active
Active Comparator group
Treatment:
Other: iTBS
iTBS sham
Sham Comparator group
Treatment:
Other: iTBS

Trial contacts and locations

1

Loading...

Central trial contact

FLAVIA TORLIZZI

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems